Intel Work in process increased by 4.1% to $6.75B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.2%, from $6.97B to $6.75B. Over 4 years (FY 2020 to FY 2024), Work in process shows an upward trend with a 6.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.97B | $6.30B | $6.66B | $6.93B | $6.16B | $7.03B | $7.57B | $7.42B | $6.64B | $6.27B | $6.20B | $6.56B | $6.29B | $6.97B | $7.43B | $7.24B | $6.48B | $6.75B |
| QoQ Change | — | +5.6% | +5.6% | +4.1% | -11.0% | +14.0% | +7.6% | -2.0% | -10.5% | -5.6% | -1.0% | +5.8% | -4.1% | +10.8% | +6.6% | -2.6% | -10.4% | +4.1% |
| YoY Change | — | — | — | — | +3.3% | +11.5% | +13.7% | +7.0% | +7.7% | -10.9% | -18.0% | -11.5% | -5.2% | +11.3% | +19.8% | +10.4% | +3.0% | -3.2% |
| % of Inventories | 67.7% | 64.3% | 61.8% | 58.0% | 50.6% | 54.8% | 57.2% | 57.1% | 55.4% | 54.6% | 55.7% | 57.1% | 56.0% | 57.8% | 60.9% | 59.0% | 57.0% | 58.8% |
| Share Change | — | -3.3pp | -2.6pp | -3.7pp | -7.4pp | +4.2pp | +2.4pp | -0.1pp | -1.7pp | -0.7pp | +1.1pp | +1.3pp | -1.1pp | +1.8pp | +3.1pp | -2.0pp | -2.0pp | +1.8pp |
We use cookies for analytics. See our Privacy and Cookie Policy.